Fundraising Fox

Neurotrope

Newark, US · Founded 2013 · Nevada corporation · 1 known investors

Biotech

Founders & leadership

RW
Robert WeinsteinExecutive
CS
Charles S. RamatExecutive

Board

LD
Larry D. Altstiel, MDBoard director
WS
William SingerVice Chairman of the Board
PE
Paul E. FreimanChairman of the Board
JM
Jay M. HaftBoard director
JG
James GottliebBoard director

Investors · 1

NGN CapitalreportedNew Yorkvia Kenneth J. Gorelick · board

Reported raises · per SEC filings

Form D private placements

$39.8M disclosed across 2 rounds · 2015–2016

▶$24.5MraisedDec 2016 · 221 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua SilvermanDirector
  • Robert WeinsteinExecutive Officer
  • James GottliebDirector
  • Shana PharesDirector
  • Kenneth GorelickDirector
  • Dan AlkonExecutive Officer
  • William SingerDirector
  • Bruce BernsteinDirector
  • Susanne WilkeExecutive Officer, Director
Offering amount
$24.5M
Amount sold
$24.5M
Sales commissions
$2.5M
Placement agents
Katalyst Securities LLC, GP Nurmenkari Inc.
First sale
Nov 2016
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3MraisedNov 2015 · 136 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert WeinsteinExecutive Officer
  • Larry D. Altstiel, MDDirector
  • William SingerDirector
  • Charles S. RamatExecutive Officer, Director
  • Paul E. FreimanDirector
  • Jay M. HaftDirector
  • James GottliebDirector
Offering amount
$20M
Amount sold
$15.3M
Sales commissions
$1.5M
Placement agents
Katalyst Securities LLC
First sale
Nov 2015
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

H.C. Wainwright raises Neurotrope stock target to $5 By Investing.cominvesting.com · Feb 2025Investors Who Bought Neurotrope (NASDAQ:NTRP) Shares Five Years Ago Are Now Down 87%finance.yahoo.com · May 2019Neurotrope Announces $22.5 Million Registered Direct Offering - BioSpacebiospace.com · Dec 2018Neurotrope Announces Private Placement of $20 Millionprnewswire.com · Nov 2016Neurotrope raises $20M, set to finish PhII Alzheimer’s test | Fierce Biotechfiercebiotech.com · Nov 2016Neurotrope, Inc., Announces Reverse Merger and Completion of $21.9 Million Private Offeringprnewswire.com · Aug 2013

Frequently asked questions

Who are Neurotrope's investors?
Neurotrope's investors include NGN Capital.
How much funding has Neurotrope raised?
Neurotrope has disclosed $39.8M raised across 2 rounds.
Where is Neurotrope headquartered?
Neurotrope is headquartered in Newark, US.